Quantinno Capital Management
AGIO icon

Quantinno Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Quantinno Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.44M Sell
43,173
-341
-0.8% -$11.9K ﹤0.01% 2482
2026
Q2 		$1.61M Buy
43,514
+15,923
+58% +$483K ﹤0.01% 2151
2026
Q1 		$933K Buy
27,591
+736
+3% +$20.9K ﹤0.01% 2222
2025
Q4 		$731K Buy
+26,855
New +$942K ﹤0.01% 2041

Other funds holding AGIO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Quantinno Capital Management's AGIO Position: Q3 2026 in Review

Quantinno Capital Management reduced its Agios Pharmaceuticals (AGIO) stake by 0.78% in Q3 2026, selling an estimated $11.9K and leaving 43,173 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2482.

Quantinno Capital Management first reported a position in AGIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.61M in Q2 2026. 175 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Quantinno Capital Management held 43,173 shares of Agios Pharmaceuticals worth $1.44M as of Q3 2026.
  • Quantinno Capital Management sold 341 Agios Pharmaceuticals shares in Q3 2026, an estimated $11.9K.
  • Agios Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2482 holding.
  • Quantinno Capital Management first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Quantinno Capital Management's Agios Pharmaceuticals position peaked at $1.61M in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.